IGM Biosciences Inc (IGMS)
10.35
-0.87
(-7.75%)
USD |
NASDAQ |
Nov 14, 13:02
IGM Biosciences Price to Book Value: 5.018 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 5.439 |
| November 12, 2024 | 5.502 |
| November 11, 2024 | 6.244 |
| November 08, 2024 | 6.317 |
| November 07, 2024 | 6.966 |
| November 06, 2024 | 7.068 |
| November 05, 2024 | 7.674 |
| November 04, 2024 | 7.606 |
| November 01, 2024 | 7.863 |
| October 31, 2024 | 8.309 |
| October 30, 2024 | 8.532 |
| October 29, 2024 | 8.368 |
| October 28, 2024 | 8.644 |
| October 25, 2024 | 8.164 |
| October 24, 2024 | 7.679 |
| October 23, 2024 | 7.771 |
| October 22, 2024 | 8.460 |
| October 21, 2024 | 7.597 |
| October 18, 2024 | 8.106 |
| October 17, 2024 | 7.771 |
| October 16, 2024 | 6.870 |
| October 15, 2024 | 7.480 |
| October 14, 2024 | 8.145 |
| October 11, 2024 | 7.272 |
| October 10, 2024 | 6.734 |
| Date | Value |
|---|---|
| October 09, 2024 | 6.588 |
| October 08, 2024 | 7.054 |
| October 07, 2024 | 6.651 |
| October 04, 2024 | 7.471 |
| October 03, 2024 | 7.224 |
| October 02, 2024 | 6.981 |
| October 01, 2024 | 7.030 |
| September 30, 2024 | 8.018 |
| September 27, 2024 | 8.242 |
| September 26, 2024 | 7.689 |
| September 25, 2024 | 7.956 |
| September 24, 2024 | 8.188 |
| September 23, 2024 | 7.752 |
| September 20, 2024 | 7.834 |
| September 19, 2024 | 8.353 |
| September 18, 2024 | 8.072 |
| September 17, 2024 | 8.571 |
| September 16, 2024 | 7.679 |
| September 13, 2024 | 5.963 |
| September 12, 2024 | 5.522 |
| September 11, 2024 | 5.692 |
| September 10, 2024 | 5.464 |
| September 09, 2024 | 4.979 |
| September 06, 2024 | 4.514 |
| September 05, 2024 | 4.969 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9062
Minimum
Oct 31 2023
18.77
Maximum
Dec 08 2020
4.938
Average
3.863
Median
Jan 18 2023
Price to Book Value Benchmarks
| Moderna Inc | 1.348 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9236 |
| Theriva Biologics Inc | 0.0543 |
Price to Book Value Related Metrics
| PS Ratio | 213.36 |
| Price | 10.35 |
| Earnings Yield | -35.17% |
| Market Cap | 613.95M |